The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival
Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs. Read this story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Science, Spoken · SpokenLayer
November 10, 20234m 53s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs.
Read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices